THE EFFICACY and SAFETY of SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB in COMBINATION WITH TRADITIONAL DMARDS in PATIENTS WITH RA AT WEEK 97 (SUMMACTA)

View/Open
Date
2014-06-01
Author
Burmester, G.
Rubbert-Roth, A.
Cantagrel, A.
Hall, S.
Leszczynski, P.
Pollak, Daniel Feldman [UNIFESP]
Rangaraj, M. J.
Roane, G.
Ludivico, C.
Mysler, E.
Bennett, M. J.
Rowell, L.
Bao, M.
Type
Resumo
ISSN
0003-4967
Is part of
Annals of the Rheumatic Diseases
DOI
10.1136/annrheumdis-2014-eular.1347
Metadata
Show full item record
Citation
Annals of the Rheumatic Diseases. London: Bmj Publishing Group, v. 73, p. 499-500, 2014.
URI
http://repositorio.unifesp.br/handle/11600/37796
Collections